Humanized mice for salmonella typhi infection new tools for an old problem

Virulence

Volumn 2, Issue 3, 2011, Pages

  Mian, M Firoz ^a   Pek, Elisabeth A ^a   Chenoweth, Meghan J ^a   Coombes, Brian K ^a   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bacterial infection; Humanized mouse; Immune responses; Pathogenesis; Salmonella typhi

Indexed keywords

ARTICLE; BACTERIAL STRAIN; IMMUNE SYSTEM; LIVER DISEASE; MENINGITIS; MORTALITY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLOSIS; SEROTYPE; TYPHOID FEVER;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

EID: 85011941621     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.3.16133     Document Type: Article

References (36)

1. Fadeel MA, Crump JA, Mahoney FJ, Nakhla IA, Mansour AM, Reyad B, et al. Rapid diagnosis of typhoid fever by enzyme-linked immunosorbent assay detection of Salmonella serotype typhi antigens in urine. Am J Trop Med Hyg 2004; 70:323-328.
2. Guzman CA, Borsutzky S, Griot-Wenk M, Metcalfe IC, Pearman J, Collioud A, et al. Vaccines against typhoid fever. Vaccine 2006; 24:3804-3811.
3. Murdoch DA, Banatvaia N, Bone A, Shoismatulloev BI, Ward LR, Threlfall EJ. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998; 351:339.
4. Threlfall EJ, Ward LR, Skinner JA, Smith HR, Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999; 353:1590-1591.
5. Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001; 7:448-50.
6. ÓBrien AD. Innate resistance of mice to Salmonella typhi infection. Infect Immun 1982; 38:948-952.
7. Pascopella L, Raupach B, Ghori N, Monack D, Falkow S, Small PL. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect Immun 1995; 63:4329-4335.
8. Carter PB, Collins FM. Growth of typhoid and paratyphoid bacilli in intravenously infected mice. Infect Immun 1974; 10:816-822.
9. Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet 2010; 11:47-59.
10. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 2002; 347:1770-1782.
11. House D, Bishop A, Parry C, Dougan G, Wain J. Typhoid fever: pathogenesis and disease. Curr Opin Infect Dis 2001; 14:573-578.
12. Wickham ME, Brown NF, Provias J, Finlay BB, Coombes BK. Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain. BMC Infect Dis 2007; 7:65.
13. Dunstan SJ, Ho VA, Duc CM, Lanh MN, Phuong CX, Luxemburger C, et al. Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis 2001; 183:1156-1160.
14. Galen JE, Pasetti MF, Tennant S, Ruiz-Olvera P, Sztein MB, Levine MM. Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol Cell Biol 2009; 87:400-412.
15. Wilson RP, Winter SE, Spees AM, Winter MG, Nishimori JH, Sanchez JF, et al. The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi. Infect Immun 2011; 79:830-837
16. Raffatellu M, Chessa D, Wilson RP, Dusold R, Rubino S, Baumler AJ. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun 2005; 73:3367-3374.
17. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, Baumler AJ. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 2008; 10:876-890.
18. Kwant-Mitchell A, Ashkar AA, Rosenthal KL. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J Virol 2009; 83:10664-10676.
19. -/- mice. Proc Natl Acad Sci USA 2006; 103:15951-15956.
20. Turrini P, Sasso R, Germoni S, Marcucci I, Celluci A, Di Marco A, et al. Development of humanized mice for the study of hepatitis C virus infection. Transplant Proc 2006; 38:1181-1184.
21. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. J Virol 2005; 79:13797-13799.
22. Kwant-Mitchell A, Pek EA, Rosenthal KL, Ashkar AA. Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. PLoS One 2009; 4:8379.
23. Firoz Mian M, Pek EA, Chenoweth MJ, Ashkar AA. Humanized mice are susceptible to Salmonella typhi infection. Cell Mol Immunol 2010; 8:83-7
24. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, Smith KD, et al. Humanized non-obese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella typhi infection. Proc Natl Acad Sci USA 2010; 107:15589-15594.
25. Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, Manz MG, et al. A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe 2010; 8:369-376.
26. Bhutta ZA, Mansoorali N, Hussain R. Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome. J Infect 1997; 35:253-256.
27. Butler T, Ho M, Acharya G, Tiwari M, Gallati H. Interleukin-6, gamma interferon and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother 1993; 37:2418-2421.
28. Bharadwaj S, Anim JT, Ebrahim F, Aldahham A. Granulomatous inflammatory response in a case of typhoid fever. Med Princ Pract 2009; 18:239-241.
29. Hornick RB. Pathogenesis of typhoid fever. J Egypt Public Health Assoc 1970; 45:247-259.
30. Gonzalez-Escobedo G, Marshall JM, Gunn JS. Chronic and acute infection of the gall bladder by Salmonella typhi: understanding the carrier state. Nat Rev Microbiol 2011; 9:9-14.
31. Santander J, Curtiss R, 3rd. Salmonella enterica Serovars Typhi and Paratyphi A are avirulent in newborn and infant mice even when expressing virulence plasmid genes of Salmonella typhimurium. J Infect Dev Ctries 2010; 4:723-731.
32. Lapaque N, Hutchinson JL, Jones DC, Meresse S, Holden DW, Trowsdale J, et al. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc Natl Acad Sci USA 2009; 106:14052-14057.
33. + cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues. Infect Immun 2009; 77:214-222.
34. Gruenheid S, Pinner E, Desjardins M, Gros P. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med 1997; 185:717-730.
35. Zaharik ML, Vallance BA, Puente JL, Gros P, Finlay BB. Host-pathogen interactions: Host resistance factor Nramp1 upregulates the expression of Salmonella pathogenicity island-2 virulence genes. Proc Natl Acad Sci USA 2002; 99:15705-15710.
36. +/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 2004; 199:231-241.